Remedent, Inc. (REMI)
OTCMKTS · Delayed Price · Currency is USD
0.0007
+0.0001 (16.67%)
At close: Jan 30, 2026

Remedent Financials Overview

Millions EUR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal YearTTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingMar '23 Mar '23 Mar '22 Mar '21 Mar '20 Mar '19
Revenue
0.050.050.40.290.221.43
Revenue Growth
-94.86%-88.53%39.10%31.23%-84.59%-34.80%
Gross Profit
0.020.020.170.150.131
Operating Income
-0.28-0.280.060.01-0.07-0.64
Net Income
-0.3-0.30.130.01-0.081.9
Earnings Per Share
-----0.09
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingMar '23 Mar '23 Mar '22 Mar '21 Mar '20 Mar '19
Cash & Investments
0.030.03000.060.06
Total Debt
------
Net Cash (Debt)
0.030.03000.060.06
Net Cash Growth
-62.02%999.25%62.62%-97.56%7.25%77.73%
Net Cash Per Share
-----0.00

Cash Flow & CapEx

Fiscal YearTTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingMar '23 Mar '23 Mar '22 Mar '21 Mar '20 Mar '19
Operating Cash Flow
-----0.51
Capital Expenditures
------
Free Cash Flow
-----0.51
Free Cash Flow Growth
-----3829.67%

Margins

Fiscal YearTTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingMar '23 Mar '23 Mar '22 Mar '21 Mar '20 Mar '19
Gross Margin
39.89%39.89%42.58%50.62%61.22%69.66%
Operating Margin
-599.97%-599.97%14.60%1.80%-30.58%-44.73%
Pretax Margin
-658.59%-658.59%32.97%3.20%-35.59%132.19%
Profit Margin
-659.55%-659.55%32.81%3.10%-35.86%132.74%
FCF Margin
-----35.39%

Valuation

Fiscal YearCurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingAug '26 Mar '23 Mar '22 Mar '21 Mar '20 Mar '19
PE Ratio
--22.50348.40-1.81
P/FCF Ratio
-----6.79
PS Ratio
0.2765.407.3810.8014.342.40